GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edan Instruments Inc (SZSE:300206) » Definitions » Cyclically Adjusted Revenue per Share

Edan Instruments (SZSE:300206) Cyclically Adjusted Revenue per Share : ¥2.50 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Edan Instruments Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Edan Instruments's adjusted revenue per share for the three months ended in Mar. 2025 was ¥0.725. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥2.50 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Edan Instruments's average Cyclically Adjusted Revenue Growth Rate was 9.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Edan Instruments was 17.90% per year. The lowest was 11.90% per year. And the median was 13.40% per year.

As of today (2025-05-31), Edan Instruments's current stock price is ¥11.58. Edan Instruments's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥2.50. Edan Instruments's Cyclically Adjusted PS Ratio of today is 4.63.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Edan Instruments was 19.37. The lowest was 3.36. And the median was 6.34.


Edan Instruments Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Edan Instruments's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edan Instruments Cyclically Adjusted Revenue per Share Chart

Edan Instruments Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.74 2.00 2.23 2.44

Edan Instruments Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 2.34 2.41 2.44 2.50

Competitive Comparison of Edan Instruments's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Edan Instruments's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edan Instruments's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edan Instruments's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Edan Instruments's Cyclically Adjusted PS Ratio falls into.


;
;

Edan Instruments Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edan Instruments's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.725/115.1156*115.1156
=0.725

Current CPI (Mar. 2025) = 115.1156.

Edan Instruments Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.244 99.500 0.282
201509 0.223 100.500 0.255
201512 0.268 100.600 0.307
201603 0.256 102.200 0.288
201606 0.299 101.400 0.339
201609 0.307 102.400 0.345
201612 0.330 102.600 0.370
201703 0.341 103.200 0.380
201706 0.376 103.100 0.420
201709 0.361 104.100 0.399
201712 0.363 104.500 0.400
201803 0.399 105.300 0.436
201806 0.435 104.900 0.477
201809 0.412 106.600 0.445
201812 0.452 106.500 0.489
201903 0.461 107.700 0.493
201906 0.470 107.700 0.502
201909 0.474 109.800 0.497
201912 0.543 111.200 0.562
202003 0.618 112.300 0.633
202006 1.578 110.400 1.645
202009 1.062 111.700 1.094
202012 0.727 111.500 0.751
202103 0.880 112.662 0.899
202106 0.651 111.769 0.670
202109 0.649 112.215 0.666
202112 0.641 113.108 0.652
202203 0.670 114.335 0.675
202206 0.806 114.558 0.810
202209 0.660 115.339 0.659
202212 0.872 115.116 0.872
202303 1.104 115.116 1.104
202306 0.777 114.558 0.781
202309 0.748 115.339 0.747
202312 0.715 114.781 0.717
202403 0.765 115.227 0.764
202406 0.826 114.781 0.828
202409 0.794 115.785 0.789
202412 0.780 114.893 0.782
202503 0.725 115.116 0.725

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Edan Instruments  (SZSE:300206) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Edan Instruments's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=11.58/2.50
=4.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Edan Instruments was 19.37. The lowest was 3.36. And the median was 6.34.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Edan Instruments Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Edan Instruments's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Edan Instruments Business Description

Traded in Other Exchanges
N/A
Address
3/F - B, Nanshan Medical Equipments Park, Nanhai Road, 1019, shekou, Nanshan, Shenzhen, CHN, 518067
Edan Instruments Inc is a China-based company engages in the design, manufacture, research and development, and sale of medical equipment. Its products include Diagnostic ECG, Patient Monitoring, Obstetrics and Gynecology, Ultrasound Imaging, In-Vitro Diagnostics, and Veterinary.
Executives
Zhang Hao Directors, executives
Xie Xi Cheng Directors, executives
Zu You Dong Directors, Directors, and Executives
Huang Yan Supervisors
Li Xiang Hua Securities Affairs Representative
He Shao Hua Supervisors

Edan Instruments Headlines

No Headlines